Search Results 1151-1160 of 17427 for alopecia

  1. A Study to Examine Financial Distress in Patients Undergoing Treatment of Locally-advanced Rectal Cancer - Mayo Clinic

    The purpose of this study is to examine the needs and gap in our understanding of financial burden experienced by rectal cancer patients from a patient ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  3. A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies - Mayo Clinic

    0) ≤ Grade 1, or to the levels dictated in the eligibility criteria with the exception of alopecia. Patient with history of confirmed progressive ...

  4. Patient Stories - Lopa Misra, D.O. - Mayo Clinic

    We are transforming healthcare! ... Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each ...

  5. Patient Stories - Alyx B. Porter, M.D. - Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  6. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS - Mayo Clinic

    ... alopecia * ARM E REGISTRATION: Absolute neutrophil count (ANC) ≥ 500/mm\^3 (obtained ≤ 7 days prior to registration) * ARM E REGISTRATION: Platelet count ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  8. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  9. Clinical trials - Oncology (Medical)

    This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior compared to ...

  10. A Study of LOXO-292 in Patients with Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer - Mayo Clinic

    Any unresolved toxicities from prior therapy greater than CTCAE Grade 1 at the time of starting study treatment with the exception of alopecia and Grade 2, ...